Who are Td alone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Td, Tetanus and Diphtheria Toxoids Adsorbed, Tetanus Toxoid Adsorbed Vaccine, Tetanus Diphtheria Vaccine, DT, tetanus diphtheria toxoids vaccine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/td-alone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Td alone — Competitive Intelligence Brief

Td alone (Td alone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Toxoid vaccine. Area: Immunology / Infectious Disease.

marketed Toxoid vaccine Tetanus toxin and diphtheria toxin Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Td alone (Td alone) — Korea University Guro Hospital. Td is a toxoid-based vaccine that provides immunization against tetanus and diphtheria by stimulating antibody production against inactivated bacterial toxins.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Td alone TARGET	Td alone	Korea University Guro Hospital	marketed	Toxoid vaccine	Tetanus toxin and diphtheria toxin
Td	Td	University of Florida	marketed	Toxoid vaccine	Tetanus toxin (tetanospasmin) and diphtheria toxin
Tetanus and Diphtheria Toxoids Adsorbed	Tetanus and Diphtheria Toxoids Adsorbed	National Institute of Allergy and Infectious Diseases (NIAID)	marketed	Toxoid vaccine
Tetanus Toxoid Adsorbed Vaccine	Tetanus Toxoid Adsorbed Vaccine	Genentech, Inc.	marketed	Toxoid vaccine	Tetanus toxin (tetanospasmin)
Tetanus Diphtheria Vaccine	Tetanus Diphtheria Vaccine	Nationwide Children's Hospital	marketed	Toxoid vaccine
DT	DT	Hoffmann-La Roche	marketed	Toxoid vaccine	Diphtheria toxin and tetanus toxin
tetanus diphtheria toxoids vaccine	tetanus diphtheria toxoids vaccine	Biogen	marketed	Toxoid vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Toxoid vaccine class)

GlaxoSmithKline · 2 drugs in this class
Genentech, Inc. · 1 drug in this class
Hoffmann-La Roche · 1 drug in this class
Hospital Clinic of Barcelona · 1 drug in this class
Korea University Guro Hospital · 1 drug in this class
London School of Hygiene and Tropical Medicine · 1 drug in this class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
Nationwide Children's Hospital · 1 drug in this class
Sanofi Pasteur, a Sanofi Company · 1 drug in this class
Sinovac Life Sciences Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Td alone — Competitive Intelligence Brief. https://druglandscape.com/ci/td-alone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab